Liabilities, Current in USD of ORAMED PHARMACEUTICALS INC. from Q3 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
ORAMED PHARMACEUTICALS INC. quarterly Liabilities, Current history and change rate from Q3 2011 to Q3 2025.
  • ORAMED PHARMACEUTICALS INC. Liabilities, Current for the quarter ending 30 Sep 2025 was $6.12M, a 16% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $6.12M +$846K +16% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $3.69M -$40K -1.07% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $5.49M -$28.1M -83.6% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $5.69M -$47.5M -89.3% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 $5.27M -$72.9M -93.3% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $3.73M +$2.67M +250% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $33.6M +$28.6M +575% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $53.2M +$47.5M +826% 31 Dec 2023 10-K 27 Mar 2025
Q3 2023 $78.2M +$71.7M +1098% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $1.07M -$5.35M -83.4% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $4.97M -$1.35M -21.4% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $5.75M -$1.62M -22% 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 $6.53M -$154K -2.31% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $6.42M +$668K +11.6% 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 $6.32M +$392K +6.61% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $7.37M +$1.63M +28.3% 31 Dec 2021 10-K 06 Mar 2023
Q3 2021 $6.68M +$2.14M +47.2% 31 Aug 2021 10-QT 30 Mar 2022
Q2 2021 $5.75M +$1.62M +39.1% 31 May 2021 10-Q 14 Jul 2021
Q1 2021 $5.93M +$777K +15.1% 28 Feb 2021 10-Q 13 Apr 2021
Q4 2020 $5.74M +$1.1M +23.7% 30 Nov 2020 10-Q 14 Jan 2021
Q3 2020 $4.54M -$772K -14.5% 31 Aug 2020 10-K 24 Nov 2021
Q2 2020 $4.14M -$1.08M -20.7% 31 May 2020 10-Q 07 Jul 2020
Q1 2020 $5.16M +$51K +1% 29 Feb 2020 10-Q 06 Apr 2020
Q4 2019 $4.64M +$477K +11.5% 30 Nov 2019 10-Q 09 Jan 2020
Q3 2019 $5.31M +$755K +16.6% 31 Aug 2019 10-K 24 Nov 2020
Q2 2019 $5.22M -$421K -7.47% 31 May 2019 10-Q 10 Jul 2019
Q1 2019 $5.1M +$386K +8.18% 28 Feb 2019 10-Q 10 Apr 2019
Q4 2018 $4.16M -$960K -18.7% 30 Nov 2018 10-Q 14 Jan 2019
Q3 2018 $4.55M -$612K -11.8% 31 Aug 2018 10-K 27 Nov 2019
Q2 2018 $5.64M +$601K +11.9% 31 May 2018 10-Q 12 Jul 2018
Q1 2018 $4.72M -$215K -4.36% 28 Feb 2018 10-Q 09 Apr 2018
Q4 2017 $5.12M +$390K +8.24% 30 Nov 2017 10-Q 11 Jan 2018
Q3 2017 $5.17M +$1.54M +42.6% 31 Aug 2017 10-K 28 Nov 2018
Q2 2017 $5.04M +$3.7M +276% 31 May 2017 10-Q 06 Jul 2017
Q1 2017 $4.93M +$3.41M +225% 28 Feb 2017 10-Q 05 Apr 2017
Q4 2016 $4.73M +$3.43M +263% 30 Nov 2016 10-Q 11 Jan 2017
Q3 2016 $3.62M +$2.13M +143% 31 Aug 2016 10-K 29 Nov 2017
Q2 2016 $1.34M +$573K +74.9% 31 May 2016 10-Q 06 Jul 2016
Q1 2016 $1.52M +$914K +151% 29 Feb 2016 10-Q 06 Apr 2016
Q4 2015 $1.3M +$477K +57.7% 30 Nov 2015 10-Q 13 Jan 2016
Q3 2015 $1.49M +$516K +53% 31 Aug 2015 10-K 25 Nov 2016
Q2 2015 $765K +$270K +54.5% 31 May 2015 10-Q 01 Jul 2015
Q1 2015 $605K +$255K +72.9% 28 Feb 2015 10-Q 03 Apr 2015
Q4 2014 $827K +$158K +23.7% 30 Nov 2014 10-Q 08 Jan 2015
Q3 2014 $973K +$475K +95.4% 31 Aug 2014 10-K 25 Nov 2015
Q2 2014 $495K +$49K +11% 31 May 2014 10-Q 14 Jul 2014
Q1 2014 $350K -$120K -25.5% 28 Feb 2014 10-Q 10 Apr 2014
Q4 2013 $669K +$334K +99.8% 30 Nov 2013 10-Q 14 Jan 2014
Q3 2013 $498K -$146K -22.7% 31 Aug 2013 10-K 14 Nov 2014
Q2 2013 $446K +$90.2K +25.3% 31 May 2013 10-Q 17 Jul 2013
Q1 2013 $469K -$113K -19.4% 28 Feb 2013 10-Q 11 Apr 2013
Q4 2012 $335K -$89.8K -21.2% 30 Nov 2012 10-Q 26 Dec 2012
Q3 2012 $644K +$203K +46% 31 Aug 2012 10-K 27 Nov 2013
Q2 2012 $356K 31 May 2012 10-Q 12 Jul 2012
Q1 2012 $582K 29 Feb 2012 10-Q 04 Apr 2012
Q4 2011 $424K 30 Nov 2011 10-Q 12 Jan 2012
Q3 2011 $441K 31 Aug 2011 10-K 12 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.